Acorah Software Products - Accounts Production15.0.600falsetrue30 November 20221 December 2021falsetrueNo description of principal activity1 December 202230 November 202330 November 2023SC681715Dr Hassan Baigiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pureSC6817152022-11-30SC6817152023-11-30SC6817152022-12-012023-11-30SC681715frs-core:CurrentFinancialInstruments2023-11-30SC681715frs-bus:PrivateLimitedCompanyLtd2022-12-012023-11-30SC681715frs-bus:FilletedAccounts2022-12-012023-11-30SC681715frs-bus:Micro-entities2022-12-012023-11-30SC681715frs-bus:AuditExempt-NoAccountantsReport2022-12-012023-11-30SC681715frs-bus:Director12022-12-012023-11-30SC6817152021-11-30SC6817152022-11-30SC6817152021-12-012022-11-30SC681715frs-core:CurrentFinancialInstruments2022-11-30
Registered number: SC681715
Hb Mediserve Limited
Unaudited Financial Statements
For The Year Ended 30 November 2023
Tyas Shaw & Co Limited
Hb Mediserve Limited
Balance Sheet
As At 30 November 2023
Balance Sheet
Registered number: SC681715
2023
2022
£
£
Current assets
7,040
7,040
Creditors: Amounts Falling Due Within One Year
(1,695)
(1,695)
NET CURRENT ASSETS
5,345
5,345
TOTAL ASSETS LESS CURRENT LIABILITIES
5,345
5,345
NET ASSETS
5,345
5,345
CAPITAL AND RESERVES
5,345
5,345
Notes
1.General Information
Hb Mediserve Limited is a private company, limited by shares, incorporated in , registered number SC681715. The registered office is 2 Clayhills Grove, Dundee, DD2 1NF.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
11
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.